Amla on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion

NCT03633630 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Syndrome

Interventions

DRUG: Amla
DRUG: Placebo

Sponsor

University of Guadalajara